Tranexamic acid for skin: How this melasma ingredient works

Tranexamic acid started out nowhere near a skincare shelf. This article covers where it came from, how it actually helps with melasma and uneven tone, the different ways it is used, how it stacks up against hydroquinone and kojic acid, and what the real safety picture looks like. It is educational content, not medical advice.

What tranexamic acid is

Tranexamic acid was developed decades ago as an antifibrinolytic, a medication that helps blood clots hold together, and it has long been used to control heavy bleeding in settings like surgery, trauma, and heavy menstrual periods. Its use in skin pigmentation is a newer, secondary application: clinicians treating patients for bleeding-related reasons and other conditions began noticing a lightening effect on pigmented skin, which led to it being studied directly for melasma and other forms of hyperpigmentation [1]. It has now been used in topical, oral, and injected forms specifically for pigmentation for over a decade.

How it works on pigmentation

Tranexamic acid does not work the same way hydroquinone or kojic acid do. Instead of directly blocking the enzyme that makes melanin, it interferes with the plasmin pathway. In simple terms, UV exposure and skin inflammation activate plasmin activity in skin cells, and that activity is part of what stimulates melanocytes, the cells that produce pigment, into overproducing melanin in areas prone to melasma. By damping down that plasmin activation, tranexamic acid reduces one of the upstream triggers for excess pigment production rather than blocking the pigment-making machinery directly [1, 2]. That is also part of why it is frequently used alongside other actives that work through different mechanisms, rather than as a stand-alone replacement for them.

Forms: Cream, serum, or oral

Tranexamic acid for pigmentation comes in a few different forms, and they are not interchangeable.

• Topical cream or serum. Applied directly to the skin, generally once or twice a day as part of a provider-set routine. This is the most common form used for melasma maintenance and is what most compounded tranexamic acid formulas are built around.
• Oral tranexamic acid. Taken by mouth as a systemic medication. This form must only be used under a physician's supervision and prescription; it is not a self-directed option, because it is absorbed into the bloodstream rather than staying local to the skin, and it carries the same safety considerations as any systemic use of the medication (more on that below).
• Intradermal or in-office injection. Used in some clinical settings, typically administered by a provider in person rather than something you would do yourself at home.

A direct randomized trial comparing oral and topical tranexamic acid for melasma over 12 weeks found both forms produced a significant reduction in melasma severity scores, with the oral group seeing a somewhat larger average reduction than the topical group, though the difference between the two was not statistically significant, and one participant in the topical group discontinued due to skin sensitivity [3]. In practical terms, that suggests topical use can be a genuinely comparable option for many people, not just a weaker fallback, and the choice between forms is reasonably one of tolerability and provider judgment rather than one clearly outperforming the other across the board.

How it compares to hydroquinone and kojic acid

None of these three ingredients is a universal "best" choice. Each works differently and the comparative evidence is mixed depending on which study and which form you look at.

Against hydroquinone specifically, one study comparing topical tranexamic acid to topical hydroquinone in women with melasma found both treatments produced meaningful improvement, with tranexamic acid generally better tolerated and hydroquinone showing a somewhat faster or stronger response in some measures [4]. For more on hydroquinone's own mechanism and safety considerations, see Hydroquinone for skin lightening.

Against kojic acid, there is less direct head-to-head research specifically pitting kojic acid against tranexamic acid, but a separate comparative study of kojic acid against hydroquinone found kojic acid tended to be more irritating and somewhat less effective than hydroquinone for facial melasma at the concentrations studied [5], which gives an indirect sense of where it sits relative to tranexamic acid's generally milder tolerability profile. For a closer look at kojic acid itself, see Kojic acid cream: what it does for dark spots and uneven tone.

In practice, many compounded formulas combine two or more of these actives rather than relying on just one, since they work through different mechanisms. Which combination, if any, makes sense for you is a provider decision based on your skin and the type of pigmentation you have. See Melasma, post-acne marks, and sun spots aren't the same thing for how the type of pigmentation shapes that choice.

Safety: What the evidence actually shows

Topical tranexamic acid is generally well tolerated. The direct comparison trial above reported mild side effects overall, with skin sensitivity being the main reason for discontinuation in a small number of cases [3]. That is a description of what the studies found, not a promise about how any individual will respond.

Oral tranexamic acid is a different conversation, and this is precisely why it requires a physician's prescription and supervision rather than being available as a self-directed option. Tranexamic acid works by stabilizing blood clots, so there has long been a theoretical and studied concern about clotting risk with systemic use. A large nationwide registry study of women using oral tranexamic acid for heavy menstrual bleeding, at doses higher than those typically used for melasma, found a meaningfully increased rate of venous thromboembolism compared to non-use, though the absolute risk was still low [6]. More recent, melasma-specific research using electronic health record data found no significant association between oral tranexamic acid at melasma-typical doses and thromboembolic events in a matched cohort [7]. The honest summary is that the evidence is not fully settled, doses and populations studied differ, and this is exactly the kind of judgment a prescribing physician is positioned to make, weighing your personal history of clotting risk, hormonal medication use, and other factors, which is not something to self-assess.

Whatever the form, tranexamic acid does not eliminate melasma permanently. Melasma is a chronic, relapsing condition, and tranexamic acid, like hydroquinone and kojic acid, is generally used to manage and reduce it over time rather than cure it outright. Consistent sun protection matters throughout, since UV exposure is one of the triggers the plasmin pathway responds to in the first place.

Common questions

Does it really help melasma?

The evidence supports a real effect. A systematic review and meta-analysis of tranexamic acid across oral, topical, and injected forms found a meaningful average reduction in melasma severity scores compared to baseline, with generally mild side effects [1]. Individual results vary, and melasma tends to be a relapsing condition, so "helps" means measurable improvement over weeks, not a permanent fix.

When should I expect to see changes?

Studies typically measure improvement at 8 to 12 weeks of consistent use rather than days or a couple of weeks [1, 3]. Treat that as a general pattern from the research, not a specific timeline for your case.

Is it compatible with retinoids?

It can be combined, but it should be planned by a provider rather than layered on your own, since retinoids can increase skin sensitivity and irritation, which may compound with any sensitivity from tranexamic acid itself. Your provider can advise on sequencing or timing if both are part of your plan.

Do I need a prescription?

For a compounded formula through a service like Luvo, yes. A licensed provider reviews your history, decides whether tranexamic acid, alone or combined with another active, is an appropriate fit, and sets the form and concentration. Oral tranexamic acid specifically should never be started without a physician's prescription and oversight, given the safety considerations above.

Next steps

Tranexamic acid can be a genuinely useful part of managing melasma and uneven tone, but which form and which combination make sense depends on your skin, your pigmentation type, and your health history, including anything relevant to clotting risk. The next step is a short intake so a licensed provider can review that and decide what fits. Nothing is prescribed or shipped without that review.

Explore Luvo's Skincare Program.

‍